Gene Expression Analysis of the Endometrium After Endometrial Biopsy in Fertile Women
NCT ID: NCT02219425
Last Updated: 2017-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2014-06-30
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcriptomic Evaluation of Endometrial Receptivity
NCT04141085
Predicting Endometrial Receptivity for Optimal Reproductive Management
NCT04107129
Endometrial Biopsy in Infertile Patients
NCT00064935
Endometriosis, Food Consumption and Fertility
NCT01946698
Endometriosis Impact on Oocyte Quality
NCT03241329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tissue is analysed and compared for changes in gene expression profile using Seq RNA
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
endometrial biopsy
endometrial biopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endometrial biopsy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 18-40 years
* BMI: 18-32
* Regular menstrual cycle
* No use of hormonal contraceptives or IUD the last 3 months
Exclusion Criteria
* Suspected intrauterine abnormalities
* Pregnancy
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Axel Forman, MD, DMsc
Role: STUDY_DIRECTOR
Departement of Gynaecology and Obstetrics, Aarhus University
Mia Steengaard Olesen, MD
Role: PRINCIPAL_INVESTIGATOR
Fertility Clinic Horsens Hospital, Aarhus University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fertility Clinic Horsens Hospital
Horsens, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Miacol-2014-2H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.